ApoGen Biotechnologies

Business Services · 1-10 Employees

View Company Info for Free

Overview

Phone Number

(206) 957-7300

Revenue

<$5 Million

Industry

Business Services Software Healthcare Software Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About ApoGen Biotechnologies

ApoGen Biotechnologies, Inc. is focused on developing a new class of therapies aimed at overcoming drug resistance in cancer by targeting key drivers of DNA mutation and tumor evolution. The company leverages innovative technologies, including blockchain, to enhance data security and patient engagement in the healthcare sector. Their solutions aim to reduce costs for healthcare providers while promoting privacy and transparency. ApoGen's intended clients include healthcare providers and patients seeking advanced cancer treatment options.Explore more
ApoGen Biotechnologies's Social MediaPopular SearchesApogen Biotechnologies IncApoGen Biotechnologies LLCApoGen BiotechnologiesApogen Technologies, Inc - Incorporated 10/4/Biotechnologies LLCSIC Code 87,873NAICS Code 54,541Show more

ApoGen Biotechnologies Org Chart

PhoneEmail
Pd

Senior Director, Biology

PhoneEmail
PD

Scientific Advisor

PhoneEmail
CS

Scientific Advisor

PhoneEmail
DY

Scientific Advisor

PhoneEmail
JB

Scientific Advisor

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is ApoGen Biotechnologies your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to ApoGen Biotechnologies

Compare insights from companies similar to ApoGen Biotechnologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

ApoGen Biotechnologies

<$5M
1-10
Private
$11M
2014
Pd
Peter de VriesSenior Director, Biology
<$5M
1-10
Private
-
2009
KP
Katherine PawelczakChief Operating Officer
<$5M
11-50
Private
-
2002
<$5M
11-50
Private
-
2007
N/A
<$5M
1-10
Private
<$5M
2010
<$5M
1-10
Private
-
2015
<$5M
1-10
Private
<$5M
2002
SG
Sagar GalwankarGlobal Operations Vice President, Marketing
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

ApoGen Biotechnologies is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

ApoGen Biotechnologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ApoGen Biotechnologies.

ApoGen Biotechnologies financials insights

Gather financial insights about ApoGen Biotechnologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2018

Series A

$11M

See All ApoGen Biotechnologies's Financials Insights

ApoGen Biotechnologies Tech Stack

A closer look at the technologies used by ApoGen Biotechnologies

ApoGen Biotechnologies News & Media

  • ApoGen Biotechnologies Raises $4m in Series A Funding

    ApoGen Biotechnologies, Inc., a Seattle, WA-based biotechnology company focused on the development of a new class of therapeutics targeting drivers of cancer genomic mutations, raised an additional $4m in Series A financing. M Ventures, the strategic, corporate venture arm of Merck KGaA, Darmstadt, Germany, and existing investors provided the new funding which brought total Series […] The post ApoGen Biotechnologies Raises $4m in Series A Funding appeared first on FinSMEs.
  • ApoGen Biotechnologies Expands Series A Financing to $11 Million and Enhances Leadership Team

    SEATTLE--(BUSINESS WIRE)--ApoGen Biotechnologies, Inc., a company developing a new class of drugs that target the underlying mechanisms that lead to the development of drug resistance by cancer cells, today announced the expansion of its Series A financing to a total of $11 million. M Ventures, the strategic, corporate venture arm of Merck KGaA, Darmstadt, Germany, and existing investors provided an additional $4 million in the company’s Series A. Concurrent with the financing, Keno Gutierrez,
Read more news

Top Business Services Companies

Frequently Asked Questions Regarding ApoGen Biotechnologies

What is ApoGen Biotechnologies's official website?
ApoGen Biotechnologies's official website is www.apogenbiotech.com
What is ApoGen Biotechnologies's Revenue?
ApoGen Biotechnologies's revenue is <$5 Million
What is ApoGen Biotechnologies's SIC code?
ApoGen Biotechnologies's SIC: 87,873
What is ApoGen Biotechnologies's NAICS code?
ApoGen Biotechnologies's NAICS: 54,541
How many employees does ApoGen Biotechnologies have?
ApoGen Biotechnologies has 1-10 employees
What industry does ApoGen Biotechnologies belong to?
ApoGen Biotechnologies is in the industry of: Business Services, Software, Healthcare Software
What is ApoGen Biotechnologies competition?
ApoGen Biotechnologies top competitors include: Nerx Biosciences, SuviCa, Senex Biotechnology, Accuronix Therapeutics
What technology does ApoGen Biotechnologies use?
Some of the popular technologies that ApoGen Biotechnologies uses are: PHP, Cloudflare Website Optimization, Cloudflare CDN, Microsoft 365
How do I contact ApoGen Biotechnologies?
ApoGen Biotechnologies contact info: Phone number: (206) 957-7300 Website: www.apogenbiotech.com
What does ApoGen Biotechnologies do?

ApoGen Biotechnologies, Inc. is focused on developing a new class of therapies aimed at overcoming drug resistance in cancer by targeting key drivers of DNA mutation and tumor evolution. The company leverages innovative technologies, including blockchain, to enhance data security and patient engagement in the healthcare sector. Their solutions aim... to reduce costs for healthcare providers while promoting privacy and transparency. ApoGen's intended clients include healthcare providers and patients seeking advanced cancer treatment options.Read More

What are ApoGen Biotechnologies social media links?
ApoGen Biotechnologies Linkedin page
Who invested in ApoGen Biotechnologies?
ApoGen Biotechnologies has 11 investors including WuXi AppTec’s Corporate Venture Fund, Eli Lilly and Company, Watson Fund, L.P and Germany.
Is ApoGen Biotechnologies a public company?
ApoGen Biotechnologies is private company therefore does not currently have an official ticker symbol
See more information about ApoGen Biotechnologies

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.